Latest AI and machine learning research in other cancers for healthcare professionals.
PURPOSE: This study aimed to evaluate the clinical value of deep learning image reconstruction (DLIR)-based dual-energy CT (DECT) in improving image quality for hepatocellular carcinoma (HCC). METHODS: This single-center retrospective analysis of a prospective cohort included patients enrolled between June 2024 and July 2025. Virtual monoenergetic images (VMI) at 40, 50, 60, and 74-keV (120 kVp-li...
Parkinson's disease (PD) is the fastest growing neurological disorder worldwide and is projected to affect unprecedented numbers of individuals by 2050. At the same time, PD research is undergoing a profound conceptual transformation. Advances in molecular neuropathology, genetics, biomarker science, artificial intelligence, multimodal imaging, digital medicine, and precision therapeutics are resh...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer-related mortality. Manual nuclear analysis in HCC...
BACKGROUND: Nursing ethics guides practice, but European Union national codes were developed in diverse socio-legal contexts, generating heterogeneous...
Hepatocellular carcinoma (HCC) is a biologically heterogeneous malignancy staged according to tumor burden and clinical status. Molecular and histopat...
BACKGROUND: The AI-HOPE Lung Cancer study is a multicenter initiative designed to integrate artificial intelligence (AI) and real-world data to improv...
Lung adenocarcinoma (LUAD) exhibits considerable heterogeneity and therapeutic resistance. Here, we integrated single-cell RNA sequencing, spatial tra...
Manual gating for plasma cell (PC) identification in multiparametric flow cytometry (MFC) is time-consuming and operator-dependent, especially when PC...
Noninvasive diagnosis and longitudinal surveillance of urothelial carcinoma (UC) remain clinically challenging. Here, we developed and prospectively v...
PURPOSE: Ovarian cancer is a heterogeneous solid tumor, whereas polycystic ovary syndrome (PCOS) is a distinct endocrine-metabolic ovarian disorder. W...
Early achievement of deep remission improves patients' outcome in chronic myeloid leukemia (CML) treatment, highlighting the need for predictive indic...
AIMS: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by poor prognosis, extensive perineural invasion (PNI), ...
RATIONALE AND OBJECTIVES: Preoperative differentiation of meningiomas, brain metastases, and gliomas remains challenging because of overlapping magnet...
PURPOSE: Obstructive sleep apnea is a common yet underdiagnosed sleep disorder in patients with atrial fibrillation (AF). Although polysomnography (PS...
Despite remarkable advances in cancer drug treatment, including chemotherapy, targeted therapy, and immunotherapy, therapeutic resistance remains a fo...
The heterogeneity and complex tumor microenvironment of lung adenocarcinoma lead to poor prognosis. Autophagy, as a key cellular process, interacts wi...
BACKGROUND, AIMS: Gastric cancer (GC) pathogenesis involves complex molecular interactions that remain incompletely understood at a biological systems...
Vestibular schwannoma (VS) is a benign tumor originating from the vestibular nerve, and its complex tumor microenvironment presents significant challe...
INTRODUCTION: Oral Potentially Malignant Disorders (OPMDs), including Leukoplakia and Erythroplakia, carry significant risks of malignant transformati...
Driven by changes in lifestyle and environmental factors, the global incidence of cancer is steadily increasing, which has established it as a leading...